welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory (PedsQLTM)
study id #: NCT03513367
condition: Duchenne Muscular Dystrophy
status: recruiting
purpose:There isn’t specific Health related quality of life measure for children with DMD in French. The aim of this study is to validate the French version of the Pediatric Quality of Life Inventory 3.0 Duchenne Muscular Dystrophy module with a multicentric study. The investigators will evaluate the following psychometric properties : convergent validity, internal validity, inter-rater reliability. The investigators would like to be able to use this scientific tool in future clinical trials.
intervention:
Duchenne Muscular Dystrophy of the PedsQL ™ 3.0 scale,
The following data of motor function
mechanism of action: No pharmaceutical intervention
results: https://clinicaltrials.gov/ct2/show/results/NCT03513367
last updated: December 04, 2019
rareRelated
-
Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular DystrophyThis study, supported by Charley's Fund,...
-
Transforming Neuromuscular Disease – The Future of Gene Therapyhttps://www.youtube.com/watch?v=wBW2GasP...
-
Magnetic Resonance and Optical Imaging of Dystrophic and Damaged MuscleThe purpose of this research study is to...
-
Phase 2b Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)Duchenne/Becker muscular dystrophy (DMD/...
-
Potential DMD Therapy Vamorolone Shows Positive Effects in Phase 2a Trial, Study ReportsVamorolone, a Duchenne muscular dystroph...
-
2D Strain Evaluation: Children With Duchenne Muscular Dystrophy Versus Healthy ChildrenCompare systolic function of left ventri...
-
Neurodevelopmental Needs in Young Boys with Duchenne Muscular Dystrophy (DMD): Observations from the Cooperative Int...Introduction: Duchenne muscular dystroph...
-
PTC Therapeutics Celebrates the Fifth Anniversary of STRIVE Grant Awards by Announcing 2019 Award WinnersSOUTH PLAINFIELD, N.J., Sept. 6, 2019 ...
-
Sarepta Therapeutics Announces Second Year of Route 79, The Duchenne Scholarship ProgramSarepta Therapeutics, Inc., the leader i...